Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer

30 Mar 2017

Abstract excerpt

// Ming Cui 1 , Xian-Shu Gao 1 , Xiaobin Gu 1 , Wei Guo 2 , Xiaoying Li 1 , Mingwei Ma 1 , Shangbin Qin 1 , Xin Qi 1 , Mu Xie 1 , Chuan Peng 1 and Yun Bai 1 1 Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China 2 Graduate School of Medicine, Hebei North University, Zhangjiakou, Hebei, China Correspondence to: Xian-Shu Gao, email: doctorgaoxs@126.com Keywords:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to DNA Repair Mechanisms
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28410213
DOI: 10.18632/oncotarget.16712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancerPMID 28410213Read ↗

BRCA2 gene mutation and prostate cancer risk. Comprehensive review and update.Semantic proximity Read ↗

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Semantic proximity Read ↗

Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate Cancer.Semantic proximity Read ↗

Germline BRCA mutation in male carriers-ripe for precision oncology?Semantic proximity Read ↗

Analysis of BRCA Germline Mutations in Chinese Prostate Cancer PatientsSemantic proximity Read ↗

[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis].Semantic proximity Read ↗

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.Semantic proximity Read ↗

The role of BRCA1 and BRCA2 in prostate cancer.Semantic proximity Read ↗

High-Grade Prostate Adenocarcinoma in a BRCA2 Germline Mutation Carrier: Precision Oncology and Familial Cascade Testing: a case reportSemantic proximity Read ↗

Prostate Cancer Risk by BRCA2 Genomic Regions.Semantic proximity Read ↗

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.